Sampling the small intestine microbiome during gut procedures
Part of Digestive system clinical trials.
This study collects samples from your digestive tract during a routine upper endoscopy to learn about the tiny organisms (microbiome) in your small intestine. The goal is to better understand gut health and possibly improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be a patient at Stanford's Digestive Health Center.
- You must be scheduled for an upper endoscopy (a scope test that looks at your stomach and small intestine) as part of your standard medical care.
- You cannot be pregnant, a newborn, or have trouble making your own medical decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
This study looks at how different ways of handling human samples affect the accuracy of gut bacteria analysis. It aims to improve testing methods, which could lead to better diagnosis and treatment for digestive conditions.
This study looks at how nerves behave in small gut tissue samples (biopsies) from people with irritable bowel syndrome (IBS) and healthy volunteers. The goal is to better understand IBS symptoms and what might be driving them.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study collects samples to learn how gut microbes, genetics, and body chemistry may relate to Crohn’s disease or ulcerative colitis. Your information and samples may help researchers understand disease patterns, but it does not test a new drug.
This study collects stool samples and health information to help develop a new test that may tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have not been diagnosed with a chronic gut disorder, you may be able to join.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.